{"id":6041,"date":"2026-07-18T12:14:09","date_gmt":"2026-07-18T12:14:09","guid":{"rendered":"https:\/\/knight-pharma.com\/web\/?page_id=6041"},"modified":"2026-07-18T12:14:10","modified_gmt":"2026-07-18T12:14:10","slug":"kpi-oxylozin","status":"publish","type":"page","link":"https:\/\/knight-pharma.com\/web\/kpi-oxylozin\/","title":{"rendered":"KPI OXYLOZIN"},"content":{"rendered":"
\n
\"\"<\/figure>\n<\/div>\n\n\n

COMPOSITION<\/mark><\/strong>
Each ml contains:
Oxytetracycline ………………………………………………. 150 mg
Tylosin ……………………………………………………….. 50 mg
Excipients ad …………………………………………………. 1 ml<\/p>\n\n\n\n

INDICATIONS<\/mark><\/strong>
For the treatment of gastrointestinal, respiratory, dermatological, urogenital, and septicemic infections caused by organisms susceptible to oxytetracycline and tylosin, including\u00a0Campylobacter, Mycoplasma, Pasteurella, Staphylococcus, Streptococcus,<\/em>\u00a0and\u00a0Treponema<\/em>\u00a0spp. in calves, cattle, goats, and sheep.<\/p>\n\n\n\n

ADMINISTRATION AND DOSAGE<\/mark><\/strong>
For intramuscular administration.<\/p>\n\n\n\n

General dosage:
\u2022 1 ml per 10 kg body weight<\/strong><\/p>\n\n\n\n

May be repeated after 48 hours<\/strong> if required.
Do not administer more than 20 ml per injection site in cattle<\/strong>, and 5 ml per site in calves, goats, and sheep<\/strong>.<\/p>\n\n\n\n

CONTRAINDICATIONS<\/mark><\/strong>
Hypersensitivity to tetracyclines or tylosin.
Do not use in animals with severe renal or hepatic impairment.
Do not administer concurrently with penicillins, cephalosporins, quinolones, or cycloserine.<\/p>\n\n\n\n

SIDE EFFECTS<\/mark><\/strong>
Local injection\u2011site reactions may occur.
Diarrhea, epigastric pain, skin sensitization, tooth discoloration in young animals, and hypersensitivity reactions have been reported.<\/p>\n\n\n\n

WITHDRAWAL PERIOD<\/mark><\/strong>
Meat: 28 days
Milk: 7 days<\/p>\n\n\n\n

STORAGE<\/mark><\/strong>
Store below\u00a025\u202f\u00b0C<\/strong>\u00a0in a cool, dry place. Protect from light.<\/p>\n\n\n\n

FOR VETERINARY USE ONLY<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

COMPOSITIONEach ml contains:Oxytetracycline ………………………………………………. 150 mgTylosin ……………………………………………………….. 50 mgExcipients ad …………………………………………………. 1 ml INDICATIONSFor the treatment of gastrointestinal, respiratory, dermatological, urogenital, and septicemic infections caused by organisms susceptible to oxytetracycline and tylosin, including\u00a0Campylobacter, Mycoplasma, Pasteurella, Staphylococcus, Streptococcus,\u00a0and\u00a0Treponema\u00a0spp. in calves, cattle, goats, and sheep. ADMINISTRATION AND DOSAGEFor intramuscular administration. General dosage:\u2022 1 …<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"class_list":["post-6041","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/6041","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/comments?post=6041"}],"version-history":[{"count":1,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/6041\/revisions"}],"predecessor-version":[{"id":6048,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/6041\/revisions\/6048"}],"wp:attachment":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/media?parent=6041"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}